Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Clindamycin 1 mg/Gm/Gentamicin 1 mg/Gm/Polymyxin B 2,000 U/Gm Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, facilitating targeted treatment or absorption of active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Clindamycin 1 mg/Gm/Gentamicin 1 mg/Gm/Polymyxin B 2,000 U/Gm Topical Gel is a specially compounded medication designed to treat a variety of skin conditions. This unique formulation combines the power of three active ingredients: clindamycin, gentamicin, and polymyxin B, each contributing to a broad spectrum of antibacterial activity.
Clindamycin is an antibiotic that functions by inhibiting the growth of bacteria. Gentamicin, an aminoglycoside antibiotic, disrupts bacterial cell wall synthesis, thereby preventing the bacteria from multiplying. Polymyxin B, a polypeptide antibiotic, disrupts the cell membrane of bacteria, leading to bacterial cell death.
This compounded formulation is dispensed as a semisolid gel through a pump mechanism, facilitating easy and precise application on the skin. This allows for targeted treatment or absorption of the active ingredients directly at the site of infection. The gel-like consistency ensures that the medication stays on the skin for a longer duration, thereby enhancing its effectiveness.
It is crucial to follow the instructions provided by your healthcare provider when using this medication. This medication should not be used for more than two weeks without consulting your healthcare provider. Overuse or misuse of antibiotics can lead to antibiotic resistance, which can make future infections harder to treat.
If you have any questions about Bayview Pharmacy's Clindamycin 1 mg/Gm/Gentamicin 1 mg/Gm/Polymyxin B 2,000 U/Gm Topical Gel, please do not hesitate to reach out to us. We are committed to providing you with the highest quality of care and service.
This topical gel formulation of Clindamycin 1 mg/Gm, Gentamicin 1 mg/Gm, and Polymyxin B 2,000 U/Gm is a semisolid formulation dispensed through a pump mechanism, facilitating easy and precise application on the skin. It is specifically designed for targeted treatment or absorption of active ingredients in a gel-like consistency. This formulation is indicated for the treatment of bacterial skin infections, including impetigo, folliculitis, and furunculosis. It is also used for the treatment of secondary bacterial infections of minor cuts, abrasions, and burns.
Patients with a known hypersensitivity to any of the components of the gel should not use this formulation. It is also contraindicated in patients with a history of renal impairment or in patients with a history of hypersensitivity to other aminoglycosides. Patients should avoid contact with the eyes and mucous membranes while using this formulation. If contact occurs, the area should be flushed with water immediately.
It is important to use this formulation for the full course of treatment, even if symptoms improve. Discontinuing the medication too soon may result in the infection returning. Any signs of local irritation, such as redness, itching, or burning, should be reported to the healthcare provider immediately. Patients should also avoid using other topical medications while using this formulation, as this may increase the risk of local irritation.
If you have any questions about this formulation or its use, please reach out to your healthcare provider for further guidance and information.
Clindamycin 1 mg/Gm/Gentamicin 1 mg/Gm/Polymyxin B 2,000 U/Gm Topical Gel is a compounded formulation that combines three potent antibiotics to effectively treat bacterial skin infections. This unique blend of Clindamycin, Gentamicin, and Polymyxin B works synergistically to inhibit bacterial growth and disrupt essential bacterial functions, thereby aiding in the eradication of the infection.
Clindamycin is an antibiotic that functions by halting the growth of bacteria, while Gentamicin, an aminoglycoside antibiotic, interferes with the production of proteins that the bacteria need to survive. Polymyxin B, a polypeptide antibiotic, disrupts the bacterial cell membrane, further inhibiting the bacteria's ability to function and survive.
This topical gel is designed for direct application to the affected skin area. It is crucial to adhere to the instructions provided by your healthcare provider when using this medication. Typically, the gel should be applied to the infected area two to three times daily. Hand hygiene is essential before and after the application of the gel. Unless advised by your healthcare provider, the treated area should not be covered with a bandage or any other covering.
Clindamycin 1 mg/Gm/Gentamicin 1 mg/Gm/Polymyxin B 2,000 U/Gm Topical Gel is indicated for the treatment of bacterial skin infections such as impetigo, folliculitis, and furunculosis.
If you have any queries or concerns about Clindamycin 1 mg/Gm/Gentamicin 1 mg/Gm/Polymyxin B 2,000 U/Gm Topical Gel, do not hesitate to reach out. We are here to assist you in understanding how this medication works and how it can help manage your bacterial skin infection.
This compounded formulation of Clindamycin 1 mg/Gm, Gentamicin 1 mg/Gm, and Polymyxin B 2,000 U/Gm is a semisolid topical gel designed for targeted treatment of various skin infections. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The active ingredients in this gel-like consistency formulation are absorbed into the skin to combat infections caused by bacteria such as Staphylococcus aureus, Streptococcus pyogenes, and Pseudomonas aeruginosa.
Additionally, this formulation can be used to treat fungal infections, such as those caused by Candida albicans. However, it is important to note that this formulation is not suitable for treating viral infections, such as those caused by the herpes simplex virus. The recommended usage is to apply the gel to the affected area twice daily, or as directed by a healthcare provider.
Patients should be aware that if any irritation or redness occurs, they should discontinue use and contact their healthcare provider immediately. This formulation is designed to provide targeted treatment for a variety of skin infections, but it is always important to consult with a healthcare provider before starting any new treatment regimen.
This is a semisolid formulation that contains Clindamycin, Gentamicin, and Polymyxin B as active ingredients. It is dispensed through a pump mechanism for easy and precise application on the skin.
The gel has a semisolid, gel-like consistency that allows for targeted treatment or absorption of the active ingredients.
The gel is applied topically on the skin. It is dispensed through a pump mechanism, which facilitates easy and precise application.
The active ingredients in this topical gel are Clindamycin (1 mg/Gm), Gentamicin (1 mg/Gm), and Polymyxin B (2,000 U/Gm).
The pump mechanism allows for easy and precise application of the gel on the skin. It ensures that the right amount of gel is dispensed each time.
It's important to use this gel as directed by a healthcare professional. It is formulated to treat specific skin conditions, so it may not be suitable for all skin issues.
Store the gel in a cool, dry place away from direct sunlight. Always keep it out of reach of children.
If you miss a dose, apply it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not apply extra gel to make up for a missed dose.
If you apply too much gel, wipe off the excess with a tissue or clean cloth. If you experience any adverse reactions, contact your healthcare provider immediately.
Before using other skincare products, consult with your healthcare provider. Some products may interfere with the effectiveness of the gel or cause skin irritation when used together.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
